Devos D[Auth] - Search Results

Year	Number of Results
1981	2
1982	1
1984	1
1986	1
1988	1
1990	1
1992	1
1995	1
1996	7
1997	5
1998	1
2000	5
2001	7
2002	7
2003	11
2004	6
2005	8
2006	23
2007	9
2008	13
2009	17
2010	20
2011	20
2012	21
2013	25
2014	28
2015	18
2016	23
2017	28
2018	24
2019	21
2020	33
2021	29
2022	2

1

Ferroptosis and its potential role in the physiopathology of Parkinson's Disease.

Mahoney-Sánchez L, Bouchaoui H, Ayton S, Devos D, Duce JA, Devedjian JC. Mahoney-Sánchez L, et al. Among authors: devos d. Prog Neurobiol. 2021 Jan;196:101890. doi: 10.1016/j.pneurobio.2020.101890. Epub 2020 Jul 26. Prog Neurobiol. 2021. PMID: 32726602 Free article. Review.

2

Glycosphingolipids and neuroinflammation in Parkinson's disease.

Belarbi K, Cuvelier E, Bonte MA, Desplanque M, Gressier B, Devos D, Chartier-Harlin MC. Belarbi K, et al. Among authors: devos d. Mol Neurodegener. 2020 Oct 17;15(1):59. doi: 10.1186/s13024-020-00408-1. Mol Neurodegener. 2020. PMID: 33069254 Free PMC article. Review.

3

Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration.

Masaldan S, Bush AI, Devos D, Rolland AS, Moreau C. Masaldan S, et al. Among authors: devos d. Free Radic Biol Med. 2019 Mar;133:221-233. doi: 10.1016/j.freeradbiomed.2018.09.033. Epub 2018 Sep 25. Free Radic Biol Med. 2019. PMID: 30266679 Review.

4

Seven Solutions for Neuroprotection in Parkinson's Disease.

Devos D, Hirsch E, Wyse R. Devos D, et al. Mov Disord. 2021 Feb;36(2):306-316. doi: 10.1002/mds.28379. Epub 2020 Nov 13. Mov Disord. 2021. PMID: 33184908 Review.

5

Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.

Devos D, Cabantchik ZI, Moreau C, Danel V, Mahoney-Sanchez L, Bouchaoui H, Gouel F, Rolland AS, Duce JA, Devedjian JC; FAIRPARK-II and FAIRALS-II studygroups. Devos D, et al. J Neural Transm (Vienna). 2020 Feb;127(2):189-203. doi: 10.1007/s00702-019-02138-1. Epub 2020 Jan 7. J Neural Transm (Vienna). 2020. PMID: 31912279 Free article. Review.

6

A ferroptosis-based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis.

Devos D, Moreau C, Kyheng M, Garçon G, Rolland AS, Blasco H, Gelé P, Timothée Lenglet T, Veyrat-Durebex C, Corcia P, Dutheil M, Bede P, Jeromin A, Oeckl P, Otto M, Meininger V, Danel-Brunaud V, Devedjian JC, Duce JA, Pradat PF. Devos D, et al. Sci Rep. 2019 Feb 27;9(1):2918. doi: 10.1038/s41598-019-39739-5. Sci Rep. 2019. PMID: 30814647 Free PMC article. Clinical Trial.

7

Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC.

Do Van B, Gouel F, Jonneaux A, Timmerman K, Gelé P, Pétrault M, Bastide M, Laloux C, Moreau C, Bordet R, Devos D, Devedjian JC. Do Van B, et al. Among authors: devos d. Neurobiol Dis. 2016 Oct;94:169-78. doi: 10.1016/j.nbd.2016.05.011. Epub 2016 May 14. Neurobiol Dis. 2016. PMID: 27189756

8

David Devos.

Devos D. Devos D. Lancet Neurol. 2012 Jul;11(7):576. doi: 10.1016/S1474-4422(12)70149-7. Lancet Neurol. 2012. PMID: 22710753 No abstract available.

9

Evolution of the nucleus.

Devos DP, Gräf R, Field MC. Devos DP, et al. Curr Opin Cell Biol. 2014 Jun;28(100):8-15. doi: 10.1016/j.ceb.2014.01.004. Epub 2014 Feb 6. Curr Opin Cell Biol. 2014. PMID: 24508984 Free PMC article. Review.

10

Clinical syndromes: Parkinsonian gait.

Ebersbach G, Moreau C, Gandor F, Defebvre L, Devos D. Ebersbach G, et al. Among authors: devos d. Mov Disord. 2013 Sep 15;28(11):1552-9. doi: 10.1002/mds.25675. Mov Disord. 2013. PMID: 24132843 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results